To verify this hypothesis, in the present study we examined the specific effect of TNFα on the promotion of tamoxifen sensitivity in ERα-positive breast cancer and identified NCOR1 as a key regulator acting downstream of TNFα. The gene discussed is NCOR1; the disease is breast cancer.